195 related articles for article (PubMed ID: 16671873)
1. Dietary supplementation of omega-3 fatty acid and circulating levels of interleukin-1beta, osteocalcin, and C-reactive protein in rats.
Vardar-Sengül S; Buduneli N; Buduneli E; Kardeşler L; Baylas H; Atilla G; Lappin D; Kinane DF
J Periodontol; 2006 May; 77(5):814-20. PubMed ID: 16671873
[TBL] [Abstract][Full Text] [Related]
2. Dietary Supplementation of Omega-3 Fatty Acid and Circulating Levels of Interleukin-1β, Osteocalcin, and C-Reactive Protein in Rats.
Vardar-Şengül S; Buduneli N; Buduneli E; Kardeşler L; Baylas H; Atilla G; Lappin D; Kinane DF
J Periodontol; 2006 May; 77(5):814-820. PubMed ID: 29539164
[TBL] [Abstract][Full Text] [Related]
3. Effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on serum interleukin-1beta, osteocalcin, and C-reactive protein levels in rats.
Vardar-Sengül S; Buduneli N; Buduneli E; Baylas H; Atilla G; Lappin D; Kinane DF
J Periodontol; 2006 Apr; 77(4):657-63. PubMed ID: 16584347
[TBL] [Abstract][Full Text] [Related]
4. Systemic low-dose doxycycline and alendronate administration and serum interleukin-1beta, osteocalcin, and C-reactive protein levels in rats.
Buduneli E; Buduneli N; Vardar-Sengül S; Kardeşler L; Atilla G; Lappin D; Kinane DF
J Periodontol; 2005 Nov; 76(11):1927-33. PubMed ID: 16274312
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic versus prophylactic plus therapeutic administration of omega-3 fatty acid on endotoxin-induced periodontitis in rats.
Vardar S; Buduneli E; Türkoğlu O; Berdeli AH; Baylas H; Başkesen A; Atilla G
J Periodontol; 2004 Dec; 75(12):1640-6. PubMed ID: 15732866
[TBL] [Abstract][Full Text] [Related]
6. The effects of selective COX-2 inhibitor/celecoxib and omega-3 fatty acid on matrix metalloproteinases, TIMP-1, and laminin-5gamma2-chain immunolocalization in experimental periodontitis.
Vardar-Sengul S; Buduneli E; Turkoglu O; Buduneli N; Atilla G; Wahlgren J; Sorsa T; Baylas H
J Periodontol; 2008 Oct; 79(10):1934-41. PubMed ID: 18834249
[TBL] [Abstract][Full Text] [Related]
7. Effects of Selective Cyclooxygenase-2 Inhibitor and Omega-3 Fatty Acid on Serum Interleukin-1β, Osteocalcin, and C-Reactive Protein Levels in Rats.
Vardar-Şengül S; Buduneli N; Buduneli E; Baylas H; Atilla G; Lappin D; Kinane DF
J Periodontol; 2006 Apr; 77(4):657-663. PubMed ID: 29539151
[TBL] [Abstract][Full Text] [Related]
8. Individual and combined effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on endotoxin-induced periodontitis in rats.
Vardar S; Buduneli E; Baylas H; Berdeli AH; Buduneli N; Atilla G
J Periodontol; 2005 Jan; 76(1):99-106. PubMed ID: 15830643
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of vasoactive intestinal peptide in escherichia coli lipopolysaccharide-induced experimental periodontitis in rats.
Gürkan A; Emingil G; Nizam N; Doğanavşargil B; Sezak M; Kütükçüler N; Atilla G
J Periodontol; 2009 Oct; 80(10):1655-64. PubMed ID: 19792856
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and laminin-5 gamma2 chain immunolocalization in gingival tissue of endotoxin-induced periodontitis in rats: effects of low-dose doxycycline and alendronate.
Buduneli E; Vardar-Sengül S; Buduneli N; Atilla G; Wahlgren J; Sorsa T
J Periodontol; 2007 Jan; 78(1):127-34. PubMed ID: 17199549
[TBL] [Abstract][Full Text] [Related]
11. Effects of combined systemic administration of low-dose doxycycline and alendronate on endotoxin-induced periodontitis in rats.
Buduneli E; Vardar S; Buduneli N; Berdeli AH; Türkoğlu O; Başkesen A; Atilla G
J Periodontol; 2004 Nov; 75(11):1516-23. PubMed ID: 15633329
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of omega-3 fatty acid supplementation on serum levels of tumour necrosis factor-alpha, C-reactive protein and interleukin-2 in type 2 diabetes mellitus patients.
Malekshahi Moghadam A; Saedisomeolia A; Djalali M; Djazayery A; Pooya S; Sojoudi F
Singapore Med J; 2012 Sep; 53(9):615-9. PubMed ID: 23023905
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 fatty acid regulates inflammatory cytokine/mediator messenger RNA expression in Porphyromonas gingivalis-induced experimental periodontal disease.
Kesavalu L; Bakthavatchalu V; Rahman MM; Su J; Raghu B; Dawson D; Fernandes G; Ebersole JL
Oral Microbiol Immunol; 2007 Aug; 22(4):232-9. PubMed ID: 17600534
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1beta and thiobarbituric acid reactive substance (TBARS) levels after phase I periodontal therapy in patients with chronic periodontitis.
Tüter G; Kurtiş B; Serdar M
J Periodontol; 2001 Jul; 72(7):883-8. PubMed ID: 11495136
[TBL] [Abstract][Full Text] [Related]
15. Alveolar bone regeneration potential of a traditional Chinese medicine, Bu-Shen-Gu-Chi-Wan, in experimental periodontitis.
Yang H; Wen Q; Xue J; Ding Y
J Periodontal Res; 2014 Jun; 49(3):382-9. PubMed ID: 24033099
[TBL] [Abstract][Full Text] [Related]
16. A p38 mitogen-activated protein kinase inhibitor arrests active alveolar bone loss in a rat periodontitis model.
Rogers JE; Li F; Coatney DD; Otremba J; Kriegl JM; Protter TA; Higgins LS; Medicherla S; Kirkwood KL
J Periodontol; 2007 Oct; 78(10):1992-8. PubMed ID: 18062121
[TBL] [Abstract][Full Text] [Related]
17. Effects of local simvastatin-alendronate conjugate in preventing periodontitis bone loss.
Price U; Le HO; Powell SE; Schmid MJ; Marx DB; Zhang Y; Wang D; Narayana N; Reinhardt RA
J Periodontal Res; 2013 Oct; 48(5):541-8. PubMed ID: 23278592
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic effect of aqueous-extract from a traditional Chinese medical herb Drynaria fortunei on rat experimental model of alveolar bone resorption].
Chen LL; Tang Q; Yan J
Zhongguo Zhong Yao Za Zhi; 2004 Jun; 29(6):549-53. PubMed ID: 15706922
[TBL] [Abstract][Full Text] [Related]
19. Effect of an aldose reductase inhibitor on alveolar bone loss associated with periodontitis in diabetic rats.
Kador PF; Hamada T; Reinhardt RA; Blessing K
Postgrad Med; 2010 May; 122(3):138-44. PubMed ID: 20463423
[TBL] [Abstract][Full Text] [Related]
20. A p38alpha selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss.
Kirkwood KL; Li F; Rogers JE; Otremba J; Coatney DD; Kreider JM; D'Silva NJ; Chakravarty S; Dugar S; Higgins LS; Protter AA; Medicherla S
J Pharmacol Exp Ther; 2007 Jan; 320(1):56-63. PubMed ID: 17041006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
